Adam L. Boxer

1.9k total citations
6 papers, 39 citations indexed

About

Adam L. Boxer is a scholar working on Physiology, Neurology and Molecular Biology. According to data from OpenAlex, Adam L. Boxer has authored 6 papers receiving a total of 39 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Physiology, 3 papers in Neurology and 1 paper in Molecular Biology. Recurrent topics in Adam L. Boxer's work include Alzheimer's disease research and treatments (3 papers), Alcoholism and Thiamine Deficiency (1 paper) and Neurological Disease Mechanisms and Treatments (1 paper). Adam L. Boxer is often cited by papers focused on Alzheimer's disease research and treatments (3 papers), Alcoholism and Thiamine Deficiency (1 paper) and Neurological Disease Mechanisms and Treatments (1 paper). Adam L. Boxer collaborates with scholars based in United States, Democratic Republic of the Congo and Netherlands. Adam L. Boxer's co-authors include Maria Carmela Tartaglia, Geoffrey A. Kerchner, Breton M. Asken, Rowan Saloner, Jessica Bove, Robert A. Stern, Charlotte E. Teunissen, Michael L. Alosco, Tania F. Gendron and Lea T. Grinberg and has published in prestigious journals such as Frontiers in Neuroscience, Alzheimer s & Dementia and Frontiers in Aging Neuroscience.

In The Last Decade

Adam L. Boxer

3 papers receiving 39 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Adam L. Boxer United States	2	21	14	12	8	7	6	39
Calvin Trieu Netherlands	5	30 1.4×	11 0.8×	14 1.2×	6 0.8×	5 0.7×	11	51
Patricio Chrem Argentina	3	21 1.0×	8 0.6×	11 0.9×	3 0.4×	4 0.6×	3	25
Suzanne E. Schindler United States	3	36 1.7×	4 0.3×	36 3.0×	5 0.6×	7 1.0×	5	61
Vanessa Pallen Canada	3	16 0.8×	6 0.4×	23 1.9×	8 1.0×	5 0.7×	4	33
Mirelle D’Mello Australia	5	30 1.4×	19 1.4×	18 1.5×	5 0.6×	9 1.3×	6	51
Marta Ibarria Spain	4	33 1.6×	31 2.2×	33 2.8×	8 1.0×	4 0.6×	8	83
Ana Balbuena-Pareja United States	4	7 0.3×	5 0.4×	10 0.8×	7 0.9×	9 1.3×	4	64
Marie Poupard France	1	19 0.9×	7 0.5×	9 0.8×	5 0.6×	4 0.6×	2	29
John Bertelson United States	4	9 0.4×	22 1.6×	8 0.7×	5 0.6×	2 0.3×	7	55
Endy Weidinger Germany	4	9 0.4×	17 1.2×	14 1.2×	3 0.4×	3 0.4×	7	47

Countries citing papers authored by Adam L. Boxer

Since Specialization

Citations

This map shows the geographic impact of Adam L. Boxer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam L. Boxer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam L. Boxer more than expected).

Fields of papers citing papers by Adam L. Boxer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam L. Boxer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam L. Boxer. The network helps show where Adam L. Boxer may publish in the future.

Co-authorship network of co-authors of Adam L. Boxer

This figure shows the co-authorship network connecting the top 25 collaborators of Adam L. Boxer. A scholar is included among the top collaborators of Adam L. Boxer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam L. Boxer. Adam L. Boxer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Ljubenkov, Peter A., Shubham Singh, Sebastian Boland, et al.. (2025). Plasma lipidome dysregulation in frontotemporal dementia reveals shared, genotype‐specific, and severity‐linked alterations. Alzheimer s & Dementia. 21(9). e70631–e70631. 1 indexed citations

2.

Teunissen, Charlotte E., Julio C. Rojas, Brandon Chan, et al.. (2025). Exploring cognitive and neuroimaging profiles of dementia subtypes of individuals with dementia in the Democratic Republic of Congo. Frontiers in Aging Neuroscience. 17. 1552348–1552348.

3.

Hardy, Emily, Ashlin R. K. Roy, Samir Datta, et al.. (2024). Reward processing deficits arise early in familial frontotemporal dementia. Frontiers in Neuroscience. 18. 1491972–1491972.

4.

Paolillo, Emily W., Rowan Saloner, Argentina Lario Lago, et al.. (2024). GDF15 as a Prognostic Biomarker of Cognitive Decline in Frontotemporal Dementia. Alzheimer s & Dementia. 20(S2). 1 indexed citations

5.

Asken, Breton M., Jessica Bove, Russell M. Bauer, et al.. (2024). Clinical implications of head trauma in frontotemporal dementia and primary progressive aphasia. Alzheimer s Research & Therapy. 16(1). 193–193.

6.

Kerchner, Geoffrey A., Maria Carmela Tartaglia, & Adam L. Boxer. (2011). Abhorring the vacuum: use of Alzheimer’s disease medications in frontotemporal dementia. Expert Review of Neurotherapeutics. 11(5). 709–717. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact